The mergers-and-acquisitions market in healthcare is alive and well so far this year. Driven by takeovers like AbbVie Inc.’s March agreement to buy cancer-drug maker Pharmacyclics Inc. for $21 billion ...
By blending vinegar’s active ingredient with cutting-edge nanoparticles, scientists created a solution that wiped out nearly ...
The story of MRSA begins just four years after methicillin entered medical practice in 1959. The bacteria had already developed resistance to the new antibiotic, demonstrating the remarkable ...
Imagine two people talking over a walkie-talkie set. Successful communication depends on them being tuned to the same frequency. If others try to communicate nearby, interference can occur, and ...
Supercomputers will take on superbugs in a new venture between pharmaceutical company GSK and UK scientists to use artificial ...
Researchers have created a new vaccine candidate to treat staph and MRSA infections. Driven by the overuse of antimicrobials, pathogens are quickly building up resistances to once-successful ...
SAN FRANCISCO — Hexachlorophene and mupirocin do not effectively remove colonies of methicillin-resistant Staphylococcus aureus (MRSA) from people with HIV, a new study shows. "For several years ...
Severe MRSA infections can be fatal. MRSA mortality rates tend to be highest in older people. Certain underlying health conditions can also increase the risk of death. Staphylococcus aureus is a ...
Leapfrog hospital safety scores, hand hygiene improvement and a possible MRSA cure caught the eye of clinical quality and infection control readers last week. The following are the 10 most-read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback